Concerning on pathway enrichment analysis, Transcription Androgen Receptor (AR) nuclear signaling and Epidermal Growth Factor Receptor (EGFR) signalling pathway were clearly shown to be the pathway targets for prostate cancer progression. The gene discussed is AR; the disease is prostate cancer.